Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-348 in Healthy Adult Volunteers
Latest Information Update: 20 Feb 2020
Price :
$35 *
At a glance
- Drugs CKD-348 (Primary) ; Levamlodipine/telmisartan
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 20 Feb 2020 New trial record